Sanofi (SNY) Stock Price, Quote, News & History

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open

$48.31

Volume / Avg.

2.56M / 2.94M

Day Range

$46.97 - $48.61

52 Wk Range

44.62 - 60.12

Market Cap

$115.20B

P/E Ratio

15.88

Dividend Yield

4.51%

Exchange

NASDAQ

RSI

Short Interest

0.29%

Days to Cover

2.45

Recent Sanofi SA News

Sanofi's Multiple Sclerosis Drug Faces Trial And Regulatory Setbacks

Sanofi said its Phase 3 PERSEUS trial of tolebrutinib missed the primary endpoint in PPMS, ending plans for regulatory filing.

Vandana Singh

Sanofi Scores Two Major China Approvals For Rare Blood Disorder Drugs

Sanofi secures China approvals for Qfitlia and Cablivi, expanding its rare hematology portfolio with new options for hemophilia and aTTP patients.

Vandana Singh

Drugmakers Briefed As Vaccine Skeptics Like RFK Jr. Probe RSV Therapy Risks

U.S. regulators are reexamining infant RSV antibody treatments as safety questions surface, prompting new FDA scrutiny of products from major drugmakers.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Key Statistics

Open

$48.31

Volume / Avg.

2.56M / 2.94M

Day Range

$46.97 - $48.61

52 Wk Range

44.62 - 60.12

Market Cap

$115.20B

P/E Ratio

15.88

Dividend Yield

4.51%

Exchange

NASDAQ

RSI

Short Interest

0.29%

Days to Cover

2.45

About

Sector

Health Care

Industry

Pharmaceuticals

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits f...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry